Published in Nature on March 08, 1979
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol (2010) 3.44
Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol (1982) 1.93
The role of cytoskeletal and cytocontractile elements in pathologic processes. Am J Pathol (1983) 1.91
Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol (1979) 1.42
Endothelial oxidative stress activates the lectin complement pathway: role of cytokeratin 1. Am J Pathol (2001) 1.33
Complement activation promotes muscle inflammation during modified muscle use. Am J Pathol (2000) 1.07
Role of Inflammation in Muscle Homeostasis and Myogenesis. Mediators Inflamm (2015) 0.93
Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae. Clin Exp Immunol (1990) 0.91
Complement-mediated binding of monocytes to intermediate filaments in vitro. Am J Pathol (1983) 0.87
Autoantibodies to intermediate filaments in sera of patients with Schistosoma mansoni infection. Clin Exp Immunol (1989) 0.81
Complement activation and regulation in preeclamptic placenta. Front Immunol (2014) 0.81
Three step purification of C1q by DNA precipitation, ion exchange and lectin affinity chromatography. J Clin Pathol (1982) 0.76
In vitro complement binding on cytoplasmic structures in normal human skin: immunoelectronmicroscopic studies. J Cell Biol (1982) 0.75
Serum complements and heart fatty acid binding protein in Bangladeshi patients with acute myocardial infarction. Heart Asia (2012) 0.75
Antibody-independent complement activation by a subpopulation of mitogen-induced human T lymphoblasts. Immunology (1980) 0.75
SH3--an abundant protein domain in search of a function. FEBS Lett (1992) 12.98
Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med (1978) 3.95
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues. Lab Invest (1982) 3.29
Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J (1998) 3.09
Distribution of fibroblast surface antigen in the developing chick embryo. J Exp Med (1975) 2.85
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
Binding of GGA2 to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor. Science (2001) 2.71
Distribution of fibroblast surface antigen: association with fibrillar structures of normal cells and loss upon viral transformation. J Exp Med (1974) 2.62
Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen. Proc Natl Acad Sci U S A (1978) 2.32
Intermediate filaments anchor the nuclei in nuclear monolayers of cultured human fibroblasts. Nature (1978) 2.28
Expression of intermediate filaments in cultured cells. J Cell Sci (1981) 2.25
Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest (1980) 2.16
An SH3 binding region in the epithelial Na+ channel (alpha rENaC) mediates its localization at the apical membrane. EMBO J (1994) 2.10
Primary structure of the brain alpha-spectrin. J Cell Biol (1989) 2.08
Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest (1983) 1.82
Human smooth muscle autoantibodies reacting with intermediate (100 A) filaments. Nature (1977) 1.82
Polarization of NK cell cytoskeleton upon conjugation with sensitive target cells. J Immunol (1983) 1.67
Expression of vimentin and cytokeratin types of intermediate filament proteins in developing and adult human kidneys. Lab Invest (1984) 1.56
Bacterial infections of free-living amoebae. Res Microbiol (2001) 1.54
High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum (1994) 1.50
Distribution of fibronectin in human tissues and relationship to other connective tissue components. Ann N Y Acad Sci (1978) 1.47
Autoantibody to "intermediate filament" in infectious mononucleosis. Clin Immunol Immunopathol (1979) 1.45
Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest (1981) 1.45
Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am J Clin Pathol (1983) 1.44
Detection of Pneumocystis carinii DNA in sputum and bronchoalveolar lavage samples by polymerase chain reaction. J Clin Microbiol (1993) 1.43
Heymann nephritis induced by kidney brush border glycoproteins. Lab Invest (1980) 1.39
305 cases of permanent intravenous pacemaker treatment for Adams-Stokes syndrome. Surgery (1966) 1.38
[Why should we defend the Scandinavian languages?]. Nord Med (1993) 1.37
The p36 substrate of tyrosine-specific protein kinases co-localizes with non-erythrocyte alpha-spectrin antigen, p230, in surface lamina of cultured fibroblasts. EMBO J (1983) 1.36
Pneumocystis carinii pneumonia: detection of parasites in sputum and bronchoalveolar lavage fluid by monoclonal antibodies. BMJ (1988) 1.34
Vear, a novel Golgi-associated protein with VHS and gamma-adaptin "ear" domains. J Biol Chem (2000) 1.33
Histopathological evaluation of apoptosis in cancer. Am J Pathol (1998) 1.31
Fluorescent antibodies and lectins stain intracellular structures in fixed cells treated with nonionic detergent. J Histochem Cytochem (1978) 1.30
Immunolocalization of a novel, cytoskeleton-associated polypeptide of Mr 230,000 daltons (p230). J Cell Biol (1983) 1.30
Glial fibrillary acidic protein and intermediate filaments in human glioma cells. Acta Neuropathol (1979) 1.29
Changes in expression of fibroblast surface antigen (SFA) during cytodifferentiation and heterokaryon formation. Differentiation (1976) 1.29
A solid phase enzyme-linked immunosurbent assay (ELISA) for the demonstration of antibodies against denatured, single-stranded DNA in patient sera. Scand J Immunol (1978) 1.29
Detection of Pneumocystis carinii in lung-derived samples using monoclonal antibodies to an 82 kDa parasite component. J Immunol Methods (1987) 1.25
Alveolar rhabdomyosarcoma. Demonstration of the muscle type of intermediate filament protein, desmin, as a diagnostic aid. Am J Pathol (1982) 1.25
Standardization of a filter-paper technique for blood sampling. Ann Trop Med Parasitol (1988) 1.24
Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cells. J Supramol Struct (1976) 1.23
Tumor-specific membrane antigens in established cell lines from gliomas. Cancer (1974) 1.22
Expression of intermediate filaments in soft-tissue sarcomas. Int J Cancer (1982) 1.21
Free-living amoebae protecting Legionella in water: the tip of an iceberg? Scand J Infect Dis (1999) 1.21
Demonstration of antibodies against Yersinia enterocolitica lipopolysaccharide in human sera by enzyme-linked immunosorbent assay. J Clin Microbiol (1979) 1.21
Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res (1995) 1.19
Laminin alpha1-chain shows a restricted distribution in epithelial basement membranes of fetal and adult human tissues. Exp Cell Res (2000) 1.18
Changes in the distribution of a major fibroblast protein, fibronectin, during mitosis and interphase. J Cell Biol (1977) 1.18
Connective tissue origin of the amyloid-related protein SAA. J Exp Med (1976) 1.16
Expression of a neural type of intermediate filament as a distinguishing feature between oat cell carcinoma and other lung cancers. Am J Pathol (1983) 1.16
Mutations in the human UDP-N-acetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. Am J Hum Genet (1999) 1.16
Prevalence of intestinal parasites in the human population of León, Nicaragua. Acta Trop (1997) 1.16
Transforming and membrane proteins. Nature (1988) 1.15
Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol (2008) 1.13
Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastruct Pathol (1984) 1.12
Distribution of the major histocompatibility complex antigens on different cellular components of human liver. Cell Immunol (1984) 1.11
Binding of C1q and complement activation by vascular endothelium. J Immunol (1981) 1.10
Characterization of human smooth muscle autoantibodies reacting with cytoplasmic intermediate filaments. Clin Immunol Immunopathol (1978) 1.10
Smooth muscle antibodies of actin and "non-actin" specificity. Clin Immunol Immunopathol (1978) 1.09
Effects of persantin and nitroglycerin on myocardial blood flow during temporary coronary occlusions in dogs. Angiologica (1967) 1.08
Bile canaliculus formation in cultured HEPG2 cells. Lab Invest (1993) 1.08
Histogenesis of granular cell tumour--an immunohistochemical and ultrastructural study. J Pathol (1984) 1.08
Differential expression of laminins and their integrin receptors in developing and adult human lung. Am J Respir Cell Mol Biol (1996) 1.08
Fibronectin in synovial fluid and tissue in rheumatoid arthritis. Eur J Clin Invest (1981) 1.07
VHS domain marks a group of proteins involved in endocytosis and vesicular trafficking. FEBS Lett (1998) 1.07
Expression of intermediate filaments in established human lung cancer cell lines. An indicator of differentiation and derivation. Lab Invest (1984) 1.07
Evidence of both anti-GBM and immune complex mediated pathogenesis in the initial phase of Goodpasture's syndrome. Clin Nephrol (1978) 1.06
Relation between serum group II pepsinogen concentration and the degree of Brunner's gland hyperplasia in patients with chronic renal failure. Gut (1985) 1.05
Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br J Cancer (1996) 1.05
Tenascin in salivary gland tumours. Virchows Arch A Pathol Anat Histopathol (1992) 1.05
Localization of amyloid-related serum protein SAA-like material to intermediate (10 nm) filaments of cultured human embryonal fibroblasts. J Exp Med (1977) 1.05
Extracellular matrix in healing CO2 laser incision wound. J Oral Pathol (1987) 1.05
Immunocytochemical studies of Alzheimer neuronal perikarya with intermediate filament antisera. J Neurol Sci (1983) 1.04
Effect of heat on extracted HIV viral infectivity and antibody activity using the filter paper technique of blood sampling. AIDS (1989) 1.04
Differentiation of kidneys antigens in the human foetus. J Embryol Exp Morphol (1969) 1.04
Reorganization of cytoskeletal and contractile elements during transition of human monocytes into adherent macrophages. Lab Invest (1982) 1.04
Transient change of organization of vimentin filaments during mitosis as demonstrated by a monoclonal antibody. Exp Cell Res (1984) 1.03
EAST, an epidermal growth factor receptor- and Eps15-associated protein with Src homology 3 and tyrosine-based activation motif domains. J Biol Chem (1998) 1.03
Detection of Pneumocystis carinii DNA by filtration of air. Scand J Infect Dis (1996) 1.03
Fibronectin in human solid tumors. Int J Cancer (1981) 1.03
Intestinal parasites in HIV-2 associated AIDS cases with chronic diarrhoea in Guinea-Bissau. Acta Trop (2001) 1.03
Distribution of the transferrin receptor in normal human fibroblasts and fibrosarcoma cells. Int J Cancer (1983) 1.02
Differential diagnosis of chordoma, chondroid, and ependymal tumors as aided by anti-intermediate filament antibodies. Am J Pathol (1983) 1.02
Effect of a xenograft on early bone formation in extraction sockets: an experimental study in dog. Clin Oral Implants Res (2009) 1.02
Fibronectin and atherosclerosis. Acta Med Scand Suppl (1980) 1.02
Parietal and visceral endoderm differ in their expression of intermediate filaments. EMBO J (1983) 1.01
Expression of intermediate filaments in normal ovaries and ovarian epithelial, sex cord-stromal, and germinal tumors. Int J Gynecol Pathol (1983) 1.01
A simple enzyme immunoassay for the demonstration of rheumatoid factor. J Immunol Methods (1979) 1.01
Nephritogenic and non-nephritogenic epithelial antigens in autoimmune and passive Heymann nephritis. Lab Invest (1984) 1.00